Insmed Inc (INSM): Next-Year EPS Estimate 142.27%
As of 2026-11-12, Insmed Inc (INSM) has a next-year EPS growth estimate of 142.27%. Featured in 3 EPS revision reports, most recently on 2026-10-31.
On 2026-11-04, analyst consensus for INSM's next-year EPS growth shifted from 144.21% to 142.27% — a negative change of 1.94 percentage points. The revised estimate has been sustained across 8 subsequent trading sessions. Current-year growth is projected at 74.39%.
What's Driving This
INSM has been rising primarily after analysts raised the next-year EPS
Generated 2026-11-11 from news as of 2026-11-10
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 142.27%
- EPS growth this year
- 74.39%
- EPS next quarter (est)
- -$0.31
- Last price
- $118.07
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-11-12 | 142.27% | 74.39% | -$0.31 | $118.07 |
| 2026-11-11 | 142.27% | 74.39% | -$0.31 | $120.75 |
| 2026-11-10 | 142.27% | 74.39% | -$0.31 | $119.49 |
| 2026-11-09 | 142.27% | 74.39% | -$0.31 | $116.10 |
| 2026-11-07 | 142.27% | 74.39% | -$0.31 | $114.40 |
| 2026-11-06 | 142.27% | 74.39% | -$0.31 | $114.40 |
| 2026-11-05 | 142.27% | 74.39% | -$0.31 | $108.76 |
| 2026-11-04 | 142.27% | 74.39% | -$0.31 | $110.00 |
| 2026-11-03 | 144.21% | 74.74% | -$0.30 | $104.44 |
| 2026-11-02 | 143.72% | 74.63% | -$0.30 | $109.31 |
| 2026-10-31 | 143.58% | 74.63% | -$0.30 | $112.58 |
| 2026-10-30 | 143.58% | 74.63% | -$0.30 | $112.58 |
| 2026-10-29 | 147.69% | 75.64% | -$0.26 | $111.59 |
| 2026-10-28 | 151.80% | 75.50% | -$0.39 | $96.98 |
| 2026-10-27 | 151.80% | 75.50% | -$0.39 | $94.96 |
| 2026-10-26 | 151.80% | 75.50% | -$0.39 | $93.33 |
| 2026-10-23 | 150.70% | 75.50% | -$0.39 | $93.39 |
| 2026-10-22 | 150.70% | 75.50% | -$0.39 | $95.06 |
| 2026-10-21 | 150.70% | 75.50% | -$0.39 | $94.04 |
| 2026-10-20 | 150.81% | 75.50% | -$0.39 | $95.67 |
| 2026-10-19 | 149.91% | 75.06% | -$0.39 | $95.29 |
| 2026-10-16 | 149.91% | 75.06% | -$0.39 | $96.27 |
| 2026-10-15 | 149.92% | 75.05% | -$0.39 | $99.21 |
| 2026-10-14 | 146.83% | 75.05% | -$0.39 | $97.79 |
| 2026-10-13 | 146.89% | 75.08% | -$0.39 | $96.79 |
| 2026-10-12 | 145.87% | 75.09% | -$0.39 | $98.56 |
| 2026-10-11 | 148.90% | 74.77% | -$0.40 | $100.60 |
| 2026-10-10 | 148.90% | 74.77% | -$0.40 | $100.60 |
| 2026-10-09 | 148.90% | 74.77% | -$0.40 | $100.60 |
| 2026-10-08 | 148.90% | 74.77% | -$0.40 | $100.48 |
Reports Featuring INSM
Recent News
- Insmed Appoints Two New Directors to Its BoardPR Newswire
- Insmed Features the Global Phase 3 PALM Clinical Development Program Evaluating Treprostinil Palmitil Inhalation Powder (TPIP) at CHEST 2026PR Newswire
- Insmed Inc (INSM) (Q2 2026) Earnings Call Highlights: BRINSUPRI Surges 49% Sequentially, ...GuruFocus.com
- Insmed Inc (INSM) (Q2 2026) Earnings Call Highlights: BRINSUPRI Surges 49% Sequentially, ...GuruFocus.com
- Insmed Raises BRINSUPRI Revenue Guidance After Strong Q2 Growth and Expands Peak Sales OutlookInvestorsHub
- Insmed Raises BRINSUPRI Revenue Guidance After Strong Q2 Growth and Expands Peak Sales OutlookInvestorsHub
- Insmed: Q2 Earnings SnapshotAssociated Press
- Insmed: Q2 Earnings SnapshotAssociated Press
- Insmed Reports Second-Quarter 2026 Financial Results and Provides Business UpdatePR Newswire
- Insmed Reports Second-Quarter 2026 Financial Results and Provides Business UpdatePR Newswire
Screen Performance
Aggregate stats across all 2145 tickers our top-EPS-revision screen has flagged over the past 225 days.
- Median return since detection
- -2.9%
- % of tickers in the green
- 43%
- Median return on winners
- +22.8%
- Large revisions captured
- 2246
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Insmed Inc's next-year EPS growth estimate?▾
As of 2026-11-12, Insmed Inc (INSM) has a next-year EPS growth estimate of 142.27%, based on analyst consensus.
When was the latest EPS estimate revision for INSM?▾
The most recent revision occurred on 2026-11-04, when analysts adjusted the next-year EPS growth estimate from 144.21% to 142.27%.
What sector and industry does Insmed Inc belong to?▾
Insmed Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. INSM appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Insmed Inc (INSM) appears here because it was detected by our daily top-EPS-revision-performer screen.